Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Amoxicillin Market Price & Analysis > Market Insights - Amoxicillin > Sinopharm Weiqida Pharmaceutical's amoxicillin API obtained European CEP certificate
— Share —

Sinopharm Weiqida Pharmaceutical's amoxicillin API obtained European CEP certificate

healthoo 2020-07-24
Shanghai Modern Pharmaceutical Co., Ltd. Announcement on Obtaining CEP Certificate for Amoxicillin API, a wholly-owned subsidiary Hereinafter referred to as "Sinopharm Weiqida") received the European Pharmacopoeia Applicability Certificate for A

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.